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via disulfide bridging and stearic interaction (11) , forming Lp(a). The latter has long been recognized as a risk factor for cardiac disease, but its exact role in vivo has remained contentious (12 
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METHODS
A detailed Methods section is provided in the Supplemental Appendix. Briefly, primary human HAVIC cell lines were generated as described previously (18, 19) Yu et al.
Lp(a) in Aortic Valve Disease Raman spectroscopy, which revealed that the spectra collected on HAVICs incubated in osteogenic medium in the presence of Lp(a) for 3 weeks showed a n 1 PO 4 peak centered at 960 cm À1 ( Figure 3A) , which is indicative of hydroxyapatite. A similar peak was found on the spectra of synthetic hydroxyapatite, bone, and enamel, as well as HAVICs collected from calcified heart valves ( Figure 3A) . HAVICs incubated in osteogenic medium for the same period but without addition of Lp(a) did not show a significant presence of phosphate-containing minerals. A complete list of peak assignments for these spectra is presented in Supplemental Appendix.
By integrating the area of the n 1 phosphate peak and dividing this value by the area of the peak at 1,440 cm À1 , which is relative to the stretching of LDL ¼ low-density lipoprotein; other abbreviations as in Figure 1 .
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To further characterize the type of calcific nodules induced by Lp(a) compared with diseased aortic valves, we estimated the degree of crystallinity of the hydroxyapatite deposits by measuring the full width at half maximum (FWHM) of the n 1 phosphate peak.
Wider peaks indicate a less crystalline material, whereas sharper peaks show a higher crystallinity.
Clearly, the peak of synthetic hydroxyapatite is much sharper than any of those found in biological samples [bone, enamel, calcified heart valves, and
Lp(a)-treated HAVICs] ( Figure 3A) . We compared the FWHM measured on all the spectra ( Figure 3C ). Yu et al.
To examine the effects of Lp Figure 5D ). PD184352
significantly increased calcium deposition ( Figure 5D ). with 50 mg/ml purified Lp(a) for 7 days in serum-free DMEM. The medium was freshly changed at days 3 and 5. The harvested media (days 3 and 7) were subjected to extracellular vesicle profiling using NanoSight NS500 (Malvern Instruments, Malvern, United Kingdom). Lp(a)-treated cells show higher particle concentration than nontreated, with *p ¼ 0.04 at day 3 in DMEM, and **p ¼ 0.0001 at day 7 in OSM; n ¼ 3 for each group. (D) Extracellular vesicle size profiling shows different particle concentration vs. particle size profiling of Lp(a)-treated HAVICs at 7 days. Each condition was sampled 5 times for size profiling using NanoSight NS500. Data were combined and presented as average particle concentration vs. particle size (mean AE SEM). Abbreviations as in Figures 1 and 2 . Yu et al.
(CTNNB1), WNT3a, WNT5b, bone morphogenetic protein-2 (BMP-2), and BMP-4 ( Table 1 ). In addition,
there was a significant increase in collagen IA1, KLF4, and myocardin and a significant decrease in a-smooth Table 1) . 
J A C C : B A S I C T O T R A N S L A T I O N A L S C I E N C E V O L . 2 , N O . 4 , 2 0 1 7
Yu et al. Yu et al.
Lp(a) in Aortic Valve Disease Figure 1 . Abbreviations as in Figures 1 and 7 .
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